Health Products & Technologies

The Health Products and Technologies Division (HPTD) is one of the four Divisions of the Authority. The mandate of the HPTD resides in Part 6 (Tobacco Control Measures), Part 7 (Organization and Responsibility) and Part 8 (Clinical Trials) of the Public Health Act of 2012, Act 851.

HPTD has overarching mandate within the FDA to regulate health products and technologies, including the regulatory oversight for the conduct of clinical trials, monitoring the safety of registered health products and technologies, and the control of tobacco products through the enforcement of relevant provisions of the tobacco control measures. It serves as the secretariat for three Technical Advisory Committees (TACs) for the safety of medicines, vaccines and biological products and Medical Devices. In addition to its core mandate, the HPTD is the implementing Division of AUDA-NEPAD’s Regional Centre of Regulatory Excellence (RCORE) capacity building programme for Clinical Trials, Marketing Authorization and Pharmacovigilance.

The Division’s mandate is implemented by four Directorates, namely:

1. Vaccines, Vigilance and Clinical Trials

2. Medical Devices, Cosmetics and Household Chemicals

3. Drugs and Herbal Medicines

4. Tobacco and Substance of Abuse